Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-25-119885
Filing Date
2025-05-14
Accepted
2025-05-14 16:31:01
Documents
50
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d864399d10q.htm   iXBRL 10-Q 480694
2 EX-31.1 d864399dex311.htm EX-31.1 10555
3 EX-31.2 d864399dex312.htm EX-31.2 10576
4 EX-32.1 d864399dex321.htm EX-32.1 3900
5 EX-32.2 d864399dex322.htm EX-32.2 3864
  Complete submission text file 0001193125-25-119885.txt   3276861

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ck0002029769-20250331.xsd EX-101.SCH 35874
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ck0002029769-20250331_cal.xml EX-101.CAL 15146
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ck0002029769-20250331_def.xml EX-101.DEF 172690
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ck0002029769-20250331_lab.xml EX-101.LAB 229606
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ck0002029769-20250331_pre.xml EX-101.PRE 207107
52 EXTRACTED XBRL INSTANCE DOCUMENT d864399d10q_htm.xml XML 342364
Mailing Address 333 SOUTH GRAND AVENUE, 28TH FLOOR LOS ANGELES CA 90071
Business Address 333 SOUTH GRAND AVENUE, 28TH FLOOR LOS ANGELES CA 90071 213-830-6300
Oaktree Acquisition Corp. III Life Sciences (Filer) CIK: 0002029769 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42383 | Film No.: 25946293
SIC: 6770 Blank Checks
(CF Office: 05 Real Estate & Construction)